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In spite of the remarkable advances of the past decade in the treatment of
pneumococcal  pneumonia,  very  little has  been  learned  of  the manner  in
which  pneumococci  are  destroyed  in  the  pneumonic  lung.  Fully  en-
capsulated  living  pneumococci  are  resistant  to  the  attack  of  phagocytic
cells  unless  previously  sensitized  by  specific  antibody  (1-3).  Since
phagocytosis  is "the  only method  so far determined  by which the host is
able  to kill  the  pneumococcus"  (4),  the  attention  of  most  investigators
has  been  centered  upon  the  rle  of  antibodies  in  recovery.  Studies  of
serological reactions in patients and experimental animals have contributed
greatly  to the knowledge  of  pneumococcal  infections in general,  but they
have  failed  to  explain  the mechanism  of  recovery  in lobar pneumonia  as
shown by the following  examples.
1.  Untreated Patients.-Although type specific antibodies usually appear in the blood
serum at the time of natural crisis, they do not invariably do so  (5).  Complete recovery
may occur at a  time  when no  circulating antibody  can  be  demonstrated  (6).  If  the
phagocytosis  of virulent  pneumococci  is  dependent  upon  specific  opsonins,  how  does
the  lung overcome  the  infection  in  the apparent  absence  of immune  bodies?
2.  Patients Treated with Antiserum.-Intravenously injected  antibody  often  brings
about rapid recovery in lobar pneumonia.  Yet considerable evidence has been advanced
that antibodies  cannot penetrate  the  lung  (7, 8),  and the action  of type  specific  anti-
serum  upon the pulmonary  lesion  is therefore not understood.  To complicate matters
further,  serological  data  have  been  published  indicating  that,  were  the antibody  able
to  enter  the  alveoli,  it  could  not  accumulate  in  sufficient  amounts  to  neutralize  the
antiphagocytic  polysaccharide  in the exudate  (9).
3.  Patients Treated by  Chemotherapy.--Drugs  of  the sulfapyridine  group  are chiefly
bacteriostatic  rather than bactericidal in the concentrations  usually attained in  treating
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human  patients  (10-12).  Nevertheless,  following  treatment  with  sulfapyridine,  pa-
tients often recover without  the aid of circulating  antibodies  (13,  14).  Since phagocy-
tosis  is  thought  to  depend  upon  specific  opsonins,  and  the  sulfapyridine  itself  kills
relatively  few  organisms, it is not at all clear how chemotherapy  brings about  the final
destruction  of pneumococci  in  the  lesion.
The  purpose of the present  series  of studies  has been  to investigate  the problem  of
recovery  in lobar  pneumonia  by  the  more  direct  methods  of pathology.  The patho-
genesis  of  experimental  pneumonia has  been  studied in  a suitable  laboratory  animal,
and the lungs of animals  treated with antiserum  and sulfapyridine have  been examined
in  detail  at  various  stages  of  the  disease.  By  correlating  the  observed  histological
changes  with  the progress of the  infection and the immune  reactions  of the  host, data
have  been  obtained  which  appear  to  have  a  direct  bearing  upon  the  mechanism  of
recovery.
This paper  deals  with  the  histopathology  and  pathogenesis  of  a lobar
pneumonia  uniformly  fatal  in  untreated  rats  and  describes  the  effect  of
type specific antibody upon the pulmonary lesion following treatment  with
antipneumococcal serum.,  Observations relating to the process of recovery
in rats  treated  by chemotherapy  will be  reported  in  a subsequent paper.
Methods
In 1935,  Nungester and Jourdonais  (15)  produced lobar pneumonia in white rats by
inoculating them intrabronchially  with pneumococci  suspended  in a viscous mixture of
mucin.  The disease produced was not uniformly fatal, and for that reason, preliminary
experiments  were  undertaken  at the start of  the present  investigation  to increase  the
severity of the infection.  A group  of  100  rats was inoculated by various  modifications
of the Nungester  technique, and although at first approximately  one  in every four rats
survived,  a  more  malignant  pneumonia  was  finally  produced  which  killed  all  of  the
untreated animals.  Changes in the method which seemed to be of importance included:
(a)  inoculation  with a younger (6  hour) culture of  pneumococci,  (b)  the use  of  a more
concentrated  (6 per cent) mixture of mucin,2 and (c)  a prolonged, light anesthesia  under
ether during which the rats were maintained in a vertical position  to allow  the mucin
to flow further  into  the  terminal  bronchi.  Elimination  of the  chance  of spontaneous
recovery greatly clarified the results of subsequent experiments designed to demonstrate
the  effect  of specific  therapy.
Animals.-White rats, varying  in weight from  180 to 250  gm.,  were obtained  from
several  breeders.  Chronic  pulmonary  lesions  of  undetermined  etiology  were  occa-
sionally encountered.  Whenever a chronic lesion was found at autopsy and its presence
interfered  with  the interpretation  of the findings  in the  pneumonic  lung,  the rat was
discarded and the experiment  repeated.  No spontaneous  lesions resembling  the  acute
experimental  pneumonia  were encountered  in  any  of the  350  rats examined.
Pneumococcus Cultures.-A Type I pneumococcus  of the A6 strain,  generously  sup-
1 A preliminary  report  of these  studies  was published in Science,  1940,  92,  15.
2 Kepl and  Gunn  (16)  have  recently  obtained  a  high  mortality  using  5  per  cent
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plied  by Dr. O. H.  Robertson,  was  used  in all  experiments.  Cultures of  the heart's
blood  of  rats dying  with  bacteriemia  were  seeded  in  defibrinated rabbit  blood  under
vaseline, incubated 24 hours, and stored in the ice box.  Under these conditions pneumo-
cocci have  been  found  to retain their  virulence  for several months  (17),  but  to  insure
maintenance of maximum virulence the organism was passed through rats at least once
every 3 weeks.
For each experiment  the inoculum  was prepared  as follows:  From the stock culture
in rabbit's blood, a transfer was made to blood broth and incubated  18 hours.  1 cc.  of
the blood  broth culture  was then  transferred  to approximately  10 cc.  of 0.05  per cent
dextrose  beef  infusion  broth  to  which  defibrinated  rabbit blood  had been  added  in a
concentration  of 1 per cent.  After 6 hours of incubation at 37°C., 1 cc. of the dextrose
blood broth culture was  diluted  1:1000  in beef infusion broth and  1 cc. of  the diluted
culture was added to 9 cc. of a mucin-saline  mixture.  0.1 cc. of the resulting suspension
was used  for intrabronchial  inoculation.
Mucin.-Finely  powdered, commercial mucin  was employed as routine.  It  was found
unnecessary to  sterilize  the mucin  or grind it further before  adding  it to  normal salt
solution.  Most consistent results were obtained when a relatively concentrated mixture
of mucin  was  used  in suspending  the  pneumococci;  the  concentration  finally  adopted
was 6 per cent.
Intrabronchial  Inoculation.-The rats  were  inoculated  according  to  the  technique
described by Jourdonais  and Nungester  (18).
Size of Inoculum.-Bacterial  counts of the inoculum were  carried out in each experi-
ment  by the pour  plate method.  The number  of organisms  in  the  0.1  cc.  of mucin
mixture varied from approximately  4,000 to  7,000.  In preliminary experiments  it was
found  that  if  fewer  pneumococci  were  used,  rats  would  occasionally  recover  spon-
taneously.
Prolonged Anesthesia.-To insure the penetration  of the inoculum  into the  terminal
bronchi,  the rats were  hung  (by  the upper  incisor  teeth)  in a vertical  position  for 30
minutes  while  still under  light  ether  anesthesia.  This  procedure  seemed  to  increase
the  severity  of  the  pneumonia  produced.
Blood Cultures.-Blood cultures were taken from the tail at frequent intervals during
the  course of the  pneumonia,  and in rats treated  with antiserum,  cultures were  made
just before  treatment  and  5 minutes after  the  injection  was completed.  A  loopful of
blood was  streaked  on  a  blood  agar plate  and incubated  for  24  hours at 37C.  The
identity  of  the  organism  cultured  was  frequently  checked  by  the  Neufeld  Quellung
reaction.  Similar cultures  were made  as  routine  from  the heart  at autopsy and  were
also taken from the pleura,  pericardium,  and lungs when indicated.
Methods of Studying Pathology.-All surviving  rats were killed  with ether.  Because
of the possibility of post mortem growth of pneumococci  in the lesion, the lungs of rats
autopsied more than one hour after death  were not considered  suitable for microscopic
study.  The  lungs  were  fixed  in Zenker-formol  solution  (5 per cent  formalin)  by  the
method of Loosli (19).  The thorax was opened and the aorta was immediately clamped.
If the heart  was still beating, it was  allowed to  do so for a moment, and then  a tight
ligature  was  placed about  its base to  isolate  the pulmonary  circulation.  If the heart
had already stopped beating, blood was forced on into the pulmonary vessels by clamping
3  Granular  mucin,  type  1701-W,  prepared  by  the  Wilson  Laboratories,  Chicago.
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the right ventricle.  In either case the pulmonary capillaries  were  sufficiently  distended
with blood  to facilitate  identification  of the  alveolar  walls in  the microscopic  sections
(see  Figs.  2,  3,  4,  6, etc.).  After  a  blood  culture had been  taken  from  the  heart,  the
lungs  were  fixed  in  situ by  injecting  the  trachea  with  Zenker-formol  solution.  The
fixative  was introduced  slowly under a pressure  of not more than  15  cm. of  water, and
was allowed  to re-expand the lungs until they again filled the thorax.  The trachea was
then tied off and the thoracic organs removed  and placed  in Zenker-formol solution  for
12  to 18 hours.  The fixed specimens  were washed  for 24 hours in  tap water  and dehy-
drated in 80 per cent alcohol.  Sagittal  blocks were cut from the single-lobed left lung,
passing through the pneumonic  lesion, and each block was further dehydrated in alcohol,
imbedded in paraffin,  sectioned,  and stained by the  Gram-Weigert  technique.
4 Direct
injection of  the  lung was  found  to  fix the  exudate  in place,  and  by  redistending  the
alveoli to their normal size, greatly clarify the histology of the pneumonic lesion (Fig. 6).
Treatment.-The rats  were  treated with  Type  I antipneumococcal  serum  obtained
through  the courtesy  of Dr. W.  G.  Malcolm  of Lederle  Laboratories.  Refined  rabbit
serum  was used throughout  these  studies,  except in  one experiment  where horse serum
was employed.  The  rabbit serum contained 6,000 units of antibody per cc.;  the horse
serum  2,500 units per  cc.  All rats were  treated with a  single intravenous  injection  of
antiserum.  A  dose  of  1 cc.  (6,000  units)  was  administered  as  routine,  but  in a  few
experiments  smaller  doses  were  given,  and  as little as  0.02  cc.  (120  units)  was  found
to be effective.
The technique  employed in  injecting serum intravenously  was as follows:  The  groin
was shaved  and the  skin  was cleaned  with iodine  and alcohol while  the rat was under
light ether anesthesia.  An incision  about 3 cm. long was made over the femoral vessels,
and  the  vein  was  exposed  by  blunt  dissection.  A  No.  26  needle  attached  to a  1 cc.
tuberculin  syringe containing the antiserum  was inserted into the femoral vein, and the
serum  was  injected slowly  over a  period of  approximately  5 minutes.  Following  the
intravenous injection  the incision was closed with a continuous suture of silk.  Although
superficial infection occurred frequently about the skin sutures, no serious deep infections
were  encountered  when  the  wound  was  properly  closed.
If the antiserum was injected rapidly, the rats sometimes  died of sudden  respiratory
failure.  The slow injection of serum caused an increase in respiratory  rate, but no other
reactions  were noted except in extremely ill rats treated late in the course of the disease.
The reaction  observed  in this latter group  is described  below.
RESULTS
Fatality Rate  among  Untreated Rats.-The  pneumococcal  pneumonia
produced  experimentally  by  the  method  outlined  was  uniformly  fatal.
All of  40 untreated rats succumbed to the disease  in less than  5 days,  the
majority  dying  within 48  hours  (see Text-fig.  1).
Extent of Lesion in  Rats Dying of  Pneumonia.-In  only  5  rats was the
pneumonia  confined  to  the  left lung.  Representative  pulmonary  lesions
4In  order  to  accentuate  the  cellular  elements  of  the  exudate,  the  Gram-Weigert
method  was  slightly  modified  by  overstaining  the  sections with  hematoxylin  and  de-
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are pictured  diagrammatically  in Text-fig.  2.  All of  the  rats  had  bacte-
riemia at the time of death, and all but one developed pleurisy, pericarditis,
or both.  The pleural and pericardial exudates were thickest in the animals
Zo
/6
/4
Alum be r  2
of
Ra ts  /0
a
4
£
,no  v  treated  ats
osuvtr,/ed tfe derje.
-Th
/  2  J3  4-  ,
?efrd orr Sv,!  in  D' Y  FoDa  oiV  Tfenrn
TEXT-FIG.  1. Survival  time  of untreated  rats  dying  of experimental  pneumococcal
pneumonia.
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TEXT-FIG.  2. Representative  pulmonary  lesions  in untreated  rats dying  of experi-
mental pneumococcal  pneumonia.  All blood  cultures  positive  at  time  of death.
which  survived longest; a condition  simulating true  empyema  was seen in
rats dying on the 4th or 5th day.  The only sign of pleurisy found in rats
dying within 36 hours was an accumulation  of  cloudy pleural fluid.  When
cloudy fluid was present, it consistently  contained pneumococci.
Evolution  of Pulmonary Lesion in Untreated Animals.-The various stages
in the development of the lesion were studied in a series of  35 rats killed at
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20 minutes and at 2, 6,  12, 18,  24,  and  36 hours after inoculation.6 5 rats
were  sacrificed  at  each  interval  and  the  lungs  were carefully examined  in
the  gross  before  being  fixed  for histological  study.  The results  are  sum-
marized in Text-fig.  3.6  20 minutes after inoculation a narrow hemorrhagic
margin  marked the  site of  injection  of  the  mucin suspension.  This very
slight hemorrhagic reaction was thought to be due to trauma.  At 2 hours
the  entire  lesion had become hyperemic  and could  be  easily distinguished
from the  surrounding  normal  lung.  The pneumonia  was  seen  to  spread
rapidly after 6 hours, and by 36 hours it had involved  nearly  the  entire left
lung.  Spread to other lobes had not occurred  in  any of the rats within  36
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TEXT-FIG.  3.  Extent  of  pulmonary  lesion  and incidence  of  bacteriemia  at  various
stages  of experimental  pneumococcal  pneumonia.
* Based on  autopsy findings in 5 rats killed at each interval.
hours.  The  consolidated  area  was  found  to  be  of  firm  consistency,  and
during the first day maintained  its dark red, hemorrhagic appearance.  At
36 hours the center  of the consolidated  area  had  become  gray,  only  the
periphery  remaining  dark  red.
The margin  of  the spreading  pneumonic  lesion presented  a  very  char-
acteristic  appearance.  Its edges were  hyperemic and extremely  irregular,
and the outer zone of the lesion as well as the surrounding normal lung were
often edematous.  The irregular hyperemic margin of  an advancing pneu-
6 Later lesions were not systematically  studied because  of the failure of the majority
of untreated rats to survive for more than 48 hours.
6 No  attempt has  been made to depict  in Text-fig.  3  the  exact location  of the  pul-
monary  lesions.  The site of inoculation  was found to vary somewhat in different ani-
mals,  but  was always  in the left lung and  was  usually  at its base.
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monia  could  easily  be distinguished  from the  clearly demarcated  edge of
arrested  lesions seen in treated rats recovering from the disease.  The site
of  inoculation  of  the  mucin  remained  visible  in most  cases  as  a  sharply
circumscribed  dark  red patch.  In rats  inoculated  with  mucin  alone  the
injected area was found to maintain this same characteristic appearance  for
nearly  a  week  and,  of  course,  differed  from  the  pneumococcal  lesion  in
that it failed to spread.
Invasion of the Blood Stream and Pleural Cavity.-Frequent blood  cul-
tures  were  taken  during  the  course  of pneumonia  in untreated  rats  and
representative  results  are  recorded  in  Text-fig.  3.  Bacteriemia  was  not
encountered  during the first 2 hours,  but 5 out of  25  blood  cultures  were
positive at 6 hours.  The blood stream was invaded in roughly half of  the
animals after  12 hours, and in over 90 per cent at the end of  the first  day.
Rats with early bacteriemia  showed the most extensive pulmonary  lesions.
Cloudy pleural fluid was present occasionally  as early as 6 hours in  rats
having positive blood cultures.  The first signs of pleurisy usually occurred,
however, at 18 or 24 hours, when most of the animals had developed bacteri-
emia.  Pleurisy in the absence of bacteriemia was extremely uncommon.
Histopathology and Pathogenesis of Pneumonia in Untreated Rats.-The
early changes occurring in the lung following the intrabronchial injection of
pneumococci  suspended  in mucin have  been  carefully  described  by  Gunn
and Nungester  (20).  A lag of several hours occurs before the pneumococci
become  numerous enough to be seen in the alveoli, and the lesion does not
take  on  the  characteristic  appearance  of  a  spreading  pneumonia  until
after  approximately  12 hours.  The  histology  of later lesions observed  in
the present  study  differed  somewhat  from  that  described  by  Gunn  and
Nungester, probably  because different methods were used in producing the
pneumonia and in fixing the lungs.  Certain essential features of the present
histological findings are therefore briefly described,  since they have a direct
bearing  upon the interpretation of later experiments.
12  to  18  hours  after inoculation  three  definite  zones  became  recognizable  in  the
pneumonic lesion.  These zones  were even more  clearly  defined after  24 and 36 hours,
and although the transition between  them was gradual,  the histology of each was suffi-
ciently characteristic  to bear particular emphasis.
1. Outer Edema Zone.-The  margin of  the  advancing  pneumonic  lesion  was  found
to be characterized  by the presence of edema fluid in  the alveoli  (Fig. 2).  The edema
fluid, which stained a light pink, contained a great many pneumococci  apparently multi-
plying freely in this favorable medium (Fig. 3).  The presence of the fluid also appeared
to afford the pneumococci an excellent means of spreading into adjacent areas  of normal
lung.  In  the outer  zone  very few, if any,  leucocytes were present  in the edema-filled
alveoli.
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2. Zone  of Early Consolidation and Phagocytosis.-Inside the  outer edema  zone a
second zone could be distinguished  in which the alveoli contained both leucocytes  and
organisms.  In the outer portion of this area, where the leucocytes  were few, pneumo-
cocci were numerous (Fig. 6); and in the inner portion the leucocytes were more prevalent
and the bacteria scarce.  Phagocytosis  of the organisms by polymorphonuclear  leuco-
cytes was a  conspicuous feature of this portion of the lesion.  In  connection with later
experiments,  it  should be  emphasized  that the phagocytic  reaction,  though definitely
present,  was  less marked  than  that seen  in rats treated  with  type specific  antibody,
there being many fewer organisms ingested per leucocyte  in the untreated animals.
3.  Inner Zone of Advanced  Consolidation.-The  thoroughness  with which  the poly-
morphonuclear  leucocytes of the alveolar exudate are able to destroy pneumococci was
clearly shown by the complete absence  of organisms  within the alveoli of the central
portion of the lesion (Figs. 7 and 8).  The alveoli and many of the bronchi in this inner
zone were packed with leucocytes.  Only occasional organisms could  still be detected
in the exudate, and these were easily distinguished from the large mucin  granules seen
in  a  few  areas  within  the alveolar  phagocytes.  Heavy  deposits  of  fibrin  were  not
uncommonly  observed after  18  hours (Fig. 9).  In  the older parts of the lesion,  local
areas of clearing were prominent, macrophages  having appeared in the resolving alveolar
exudate  (Fig.  8).
Two additional histological findings deserve special emphasis, since they suggest the
mode of  spread of pneumococci to other lobes and to the pleural cavity.  The presence
in  large bronchi  of  appreciable  amounts  of  pneumococcus-laden  edema fluid  was  re-
peatedly noted in sections from rats with rapidly advancing pneumonia (Fig. 5).  Ham-
burger and Robertson  have demonstrated  (21)  in dogs that this watery bronchial exudate
contains  myriads  of  organisms  and  is responsible  for the  spread  of  the  infection  from
one  lobe  to  another.  The  frequency  with  which the  bronchial  edema  fluid  has  been
noted  in  the present  study  indicates  that  the  same  mechanism  may  operate  in  rats.
The presence  of large numbers of pneumococci  in edema-filled  alveoli bordering  on  the
pleural cavity  (Fig. 4)  suggests  that pleurisy  may be caused  by the direct penetration
of pneumococci through the visceral pleura.  It  is conceivable that the organisms invade
the  pleura  by way  of  the lymphatics,  draining outward  at the  periphery  of the  lung,
but in the face of the present histological findings, the possibility of pneumococci  passing
directly  into  the pleural  cavity  cannot be  excluded.
The histopathology  of the  24 and  36  hour pneumonia  was  essentially  the  same  as
at 18  hours, except  for the extent of the  lesion.  Rats dying after 2  or more days  also
showed  the  same histological  changes  in  the  lungs,  except  that the  older lesions  were
characterized by a more extensive  zone of advanced  consolidation in which local areas
of clearing were relatively numerous.
Experiments on the Action of Antiserum.-Five separate experiments  were
carried out in which rats were treated 2, 6, 12,  18, and 24 hours after inocu-
lation.  21 rats were inoculated in each  experiment, 3 serving as untreated
controls.  The  18 treated animals were sacrificed in groups of 3 at different
intervals  following  treatment.  The  lungs  of  each  rat were  carefully  ex-
amined  in the gross before being  fixed for histological  study.  The results
of  the first four experiments are  summarized  in Text-figs.  4 to  7; the fifthW.  BARRY  WOOD,  JR.
experiment,  in  which  rats  were  treated  after  24 hours,  is described  later
under  a  separate  heading.
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TEXT-FIG.  4.  Effect upon pulmonary  lesion  of type  specific antiserum  administered
intravenously  2  hours  after  inoculation.
* Based on  autopsy findings  in  3  rats killed at each  interval.
**  Untreated rats died in less than  70 hours.
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TEXT-FIG.  5. Effect  upon  pulmonary  lesion  and  bacteriemia  of
serum  administered  intravenously  6 hours  after inoculation.
* Based  on autopsy  findings  in  3 rats killed at each interval.
**  Untreated  rats died in less than 70 hours.
type  specific  anti-
The Effect  of Serum  Treatment upon Fatality Rate.-No deaths  due  to
pneumonia  occurred  among  the  76  animals  treated  within  18  hours  after
inoculation,  although many showed  bacteriemia  at the time  of treatment.
12 rats were allowed to live for one week and  12 more for 4 days before being
sacrificed.  Histological  examination  of the  lungs  indicated  in  each  case
that the  pneumococcal  infection  had completely  subsided.
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The Effect  of Antiserum upon the Spread of the Pneumonic Lesion.-In
each of the first four experiments the spreading lesion was promptly arrested
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TEXT-FIG.  6.  Effect  upon  pulmonary  lesion  and  bacteriemia
serum administered  intravenously  12  hours after  inoculation.
* Based on autopsy findings in  3  rats killed at each  interval.
**  Untreated rats died in less than 90 hours.
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TEXT-FIG.  7.  Effect  upon  pulmonary  lesion  and  bacteriemia  of type  specific  anti-
serum  administered intravenously  18  hours  after inoculation.
* Based  on  autopsy findings  in  3  rats killed at each  interval.
** Untreated  rats died in less  than  70 hours.
by treatment.  When  serum  was  administered  2 hours  after  inoculation,
the lesion  remained  small; it was slightly larger  18 hours after treatment,
but had regressed to its original size by the end of one week.  The effect of
antiserum upon the 6, 12, and 18 hour pneumonias was likewise pronounced.W.  BARRY  WOOD,  JR.
Although the area of consolidation was somewhat larger at the time of treat-
ment  in  each  succeeding  experiment,  the  infection  was  always  quickly
controlled  by  serum  therapy.
The gross appearance of the spreading lesion changed noticeably following
treatment.  The  margin  of  the  consolidated  area  became  sharply  de-
marcated  and  lost  the  irregular  hemorrhagic  border  characteristic  of an
advancing  pneumonia.  The entire  lesion  gradually  became  gray in  color
and in its center there appeared small patches of soft normal lung indicating
that resolution  had begun.  These changes in the gross appearance  of the
lesion made it a  simple matter to differentiate  at  autopsy between an ac-
tively spreading pneumonia and one arrested by serum therapy.
The original area of lung injected with mucin remained firm and dark red,
simulating exactly  the lesion observed in rats inoculated with mucin alone.
The  mucin  area  showed  no  signs  of  spreading  and  could  be  clearly  dis-
tinguished from the surrounding pneumococcal lesion.
The  Effect of Antiserum upon Bacteriemia and Pleurisy.-As shown  in
Text-figs.  5,  6,  and  7 the blood stream of bacteriemic  rats cleared  rapidly
following  serum  therapy.  None  of  the  animals  treated  at  2 hours  had
bacteriemia, but 2 at 6 hours, exactly half at  12 hours, and roughly  80 per
cent at  18 hours had positive blood cultures just before treatment.  When
the bacteriemia was light, the blood became  sterile a few minutes after the
injection of  serum.  When the initial blood culture showed  many  colonies
per cc., the second culture taken 5 minutes after treatment usually contained
many fewer organisms but seldom was  sterile.  In all but 2 rats the blood
cultures  were  negative  at the time  of  autopsy.  These  2 showed  positive
cultures  6  hours  after  treatment,  although  in  both  cases  the  number  of
colonies per  cc.  was markedly diminished.  No  rat developed  bacteriemia
following  therapy.
Signs of pleurisy were noted only in animals treated  18 hours after  being
infected.  In this group all 9 rats sacrificed 42 hours or more after treatment
showed  between  the  visceral and  parietal  pleura small areas  of  dense  ad-
hesions  indicative  of  localized  pleural  infections  (see  Text-fig.  7).  No
generalized  pleurisy or  empyema, as  seen in untreated rats, was  observed
in any of  these  animals,  the serum  treatment having  apparently  caused  a
localization  of  the  pleural  infection.
The  Action of  Type  Specific Antibody upon  the  Pulmonary Lesion.-In
order  to  investigate  the  effect  of antibody  upon  the pneumococci  in  the
lesion, microscopic sections were made of the lungs of all rats killed at inter-
vals after  treatment.  In rats treated  2 and 6 hours after inoculation the
pneumonic process had not developed sufficiently to make histological study
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profitable.  Under the influence of antibody the organisms were apparently
destroyed  by phagocytosis  before  they had had a chance  to multiply suffi-
ciently  to produce  the typical  pneumococcal  lesion.  In rats treated  after
12  and  18 hours,  however,  the pneumonia  was well  advanced.  Although
the  18 hour pneumonia was more  extensive than that treated at  12  hours,
the evolution of the lesion following  treatment was essentially  the same  in
both cases and may be described  as follows:-
One  hour after  treatment  pneumococci  could  be  seen  agglutinated  in  the  alveoli,
7
particularly  in  the  edema  zone  at  the  margin  of the  lesion  (Figs.  10  and  11).  This
agglutination  reaction  became  more  marked  at  6  hours,  when  practically  all of  the
extracellular  organisms  had  congregated  in  large clumps.8 Many  of  the pneumococci
seemed  to adhere  to  the  alveolar  walls  as  well  as  to each  other  (Fig.  11).  Even  the
organisms  in  large  bronchi  (Fig.  12)  and  those  well  within  the  area  of consolidation
(Fig.  13)  were  agglutinated.  Careful examination  of the  clumped  cocci  revealed  cap-
sular  swelling  typical  of  the  Neufeld  Quellung  reaction  (Figs.  14  and  15).  In  many
areas  where  leucocytes  and  pneumococci  were  present  in  the  alveoli marked  phagocy-
tosis had  occurred  (Fig.  16);  each leucocyte  was loaded  with bacteria,  the capsules  of
which were  often visibly swollen  (Fig.  17).  The phagocytic reaction  was most marked
in the  zone of early  consolidation  bordering  on  the edema-filled  alveoli at the  margin
of the  lesion.  In  the central  zone  of  advanced  consolidation,  as in untreated  rats no
pneumococci  were  present.
Within  6  hours  after  treatment  the  edema  zone  at  the  edge  of  the  lesion  became
narrower  than  that  seen  in  untreated  animals  and  after  18  hours  it had disappeared
entirely  (Fig.  18).  Its  disappearance  was  apparently  due  to the  agglutination  of  the
pneumococci  which  immobilized  them  in  edema-filled  alveoli  and  allowed  them  to be
overtaken by leucocytes.  The extension of the leucocytic exudate into alveoli previously
containing  only  edema  fluid and  organisms  accounted  for the  slight progression  of the
gross  lesion  which  occurred  during  the first  18  hours  after  treatment.  At  the  same
time more organisms  were phagocytized, until at the end of 18 hours few could be found
extracellularly.  Within  42  hours  most  of  the  pneumococci  had  been  completely  de-
stroyed  by phagocytic  cells  (Fig.  19).  4 days  after treatment  the  alveolar  walls were
7 In experiments  on  untreated  rats it  was  found  that  pneumococci  growing  in  the
presence  of free  mucin are  often  clumped together.  No conclusions,  therefore,  can be
drawn  regarding  agglutination  of  organisms  in  alveoli containing  free  mucin.  By  18
hours  relatively  little  mucin  remains  in  the  lesion,  and  only  organisms  contained  in
mucin-free  alveoli  are  considered  in  describing  the  effect  of the  antiserum.
s The increase  in the size of  the clumps seen at 6 hours was apparently due  not only
to  a  more complete  agglutination  reaction  but  also to  the multiplication  of organisms
already  agglutinated.  It  is  well known  that pneumococci  will continue  to multiply  in
clumps when grown  in  the presence  of  homologous  antibody.  It  seems  unlikely that
such masses  of  organisms  can be destroyed  by phagocytosis  alone,  and  it is suggested
that autolysis  may be an  important factor  in  the process  of destruction.  This view is
supported  by the fact that many  of the clumped  cocci are Gram-negative  after 6 to 18
hours in sections  stained  by  the method of Brown  and  Brenn  (22).W.  BARRY  WOOD,  JR.
noticeably  thickened, and the macrophage  reaction  (23) became prominent.  At the end
of one week only large pale macrophages remained  in  the alveoli and the lesion  showed
clearing.
Lesion Produced by Mucin Alone.-In rats inoculated  with mucin  alone
two histological  findings of importance  were noted after the  4th day.  One
was the presence of occasional localized sterile abscesses usually arising from
small bronchi  near the periphery of  the lung; the other was metaplasia  of
tlhe walls of a few peribronchial  alveoli  which  became lined with columnar
epithelium.  Both  of these  changes  were  found  in  the  lungs  of  rats  re-
covering from pneumonia  following  serum  therapy.  They were evidently
due to the action of mucin and were easily distinguished  from the pneumo-
coccal portion of the lesion.
The Effect of Antiserum Administered after 24 Hours.-18  rats were treated
24 hours after inoculation and the surviving  animals were  sacrificed  at the
same intervals as in the previous  experiments.  All but 2 had bacteriemia
at the time of treatment.  11 of the animals survived and at autopsy showed
gross lesions similar to those seen in rats treated 18 hours after inoculation.
The  lesions  were  slightly  more  extensive  but  otherwise  similar  to  those
already  described.  Localized  pleurisy  was  noted  in  the  rats  sacrificed
after 4  days,  and in one  animal  killed  at  the end  of  a week  there was  a
massive pericardial  effusion  containing viable Type I pneumococci.
The 7 remaining rats all died within 18 hours of treatment; 2 succumbed
during  the  injection  of  serum.  Each  animal  showed  evidence  of  marked
pulmonary edema at the time of  death with foamy hemorrhagic fluid exud-
ing  from  the  nostrils.  Autopsy  findings  were  essentially  similar  in  each
case.  The lung was  extremely hemorrhagic  and  edematous  in  the  gross;
histological examination revealed large clumps of agglutinated pneumococci
and  extensive  hemorrhages  into  the  alveoli.  In  many  areas  there  was
necrosis  of  cells  in the  alveolar exudate  and in the  alveolar walls.  In all
but one rat surviving  more than  6 hours after treatment  the blood stream
had  become  sterilized  as  the result  of  therapy.
No  definite  explanation  can  be given  for the  fatal reaction  observed  in
this group of animals.  Because  all  of the  rats died within  18 hours  after
receiving serum, and more than half had negative blood cultures at the time
of  death, it would  appear that they died of a violent  reaction to the anti-
serum rather than of the pneumococcal  infection itself.  All of the animals
were  acutely  ill  at  the  time  of  treatment;  several  were  moribund.  The
reaction  closely resembled that occasionally observed when a large dose of
antiserum  is given  to a patient  already  in a state  of  collapse  from  severe
pneumococcal pneumonia.  Under these conditions death not uncommonly
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results  from  a  reaction  characterized  by  pronounced  pulmonary  edema
(24).  The mechanism of the reaction is not understood,  and an attempt is
being made to study it further.
Because of the failure of the majority of infected rats to live more than 48
hours, it was impossible to investigate systematically the effect of antiserum
upon later lesions.  Since there had invariably developed by the end of the
2nd day an advanced pleural or pericardial  infection, which was unaffected
by antiserum, accurate  evaluation of late treatment  was not possible.  As
will be pointed out below, however, there is little reason to believe that the
action  of  antibody  upon  the  intrapulmonary  infection  is  significantly
changed  by the  age  of  the lesion.
Promptness of  Agglutination Reaction.-Agglutination of  pneumococci
was observed  in lungs fixed as soon as  10 minutes after the start of  serum
therapy.  The reaction began quickly but was not complete until sometime
between 1 and 6 hours after treatment.
Necessary Dosage of Antiserum.-Although a dose of  6,000  units of  anti-
body was  used in all of  the  experiments  described  above,  as little  as  120
units was  found  to  be effective  in treating  rats with  12  hour pneumonia.
The rats not only survived the infection when given this small dose but the
lungs of animals sacrificed  6 hours after treatment  contained  agglutinated
and opsonized pneumococci in the alveoli.  When only 12 units of antibody
were administered, the rats failed to survive and no agglutination or opsonic
effect  was observed in the lungs.
The Action of Horse Serum upon the Pulmonary Lesion.-The antibody
contained in antipneumococcal  horse serum is known to  be of larger  molec-
ular  size  than the  corresponding  rabbit  antibody  (25,  26).  It  has  been
suggested that the antibody of rabbit serum may be able to penetrate tissues
more  readily  (27)  and  may,  therefore,  be  more  effective  as  a therapeutic
agent.  In  the present  study antipneumococcal  horse serum  was found  to
exert the same  effect upon thepulmonary  lesion as did rabbit serum.  The
specific  antibodies  contained  in  horse  serum  penetrated  the  lung,  as  evi-
denced by the presence  of agglutinated  and opsonized pneumococci  within
the alveoli.
The Type Specificity of the Antibody Effect.-Histological examination of
the lungs of rats treated with Type II antiserum showed that heterologous
antibody  had no effect  upon the pneumonic  lesion.
COMMENT
The pathology of experimental  pneumonia in rats was found to simulate
closely that of spontaneous lobar pneumonia  in man.  The histology of theW.  BARRY  WOOD,  JR.
pulmonary lesion was essentially the same as that described  by Loeschcke
(28) in human patients.  The significance of bacteriemia and the occurrence
of  extrapulmonary  complications  such  as  pleurisy,  empyema,  and  peri-
carditis also seemed to be the same in the two diseases.  The study of the
pathology of the experimental disease in rats was greatly facilitated by the
fact that a sagittal section of the unilobar left lung could be mounted on a
single microscopic slide.  This made it possible to examine the lesion as a
whole, to note the transition between histological changes in different areas,
and particularly to determine the relation of the margin of the pneumonia
to  the  surrounding  normal  lung.
The mode of spread of pneumococci through the lung in lobar pneumonia
has long been  a subject  of controversy.  Two  general  theories  have been
evolved  from  the observations  of  many  investigators:  The first  favors  an
extension of  the infection  through  the interstitial  tissues  and particularly
the lymphatics  of the  lung; the  second  emphasizes  the passive  spread of
organisms  in the  alveolar edema fluid in response  to the  action of gravity
and variations in intrapulmonary  pressure.  The importance  of  lymphan-
gitis  in  the  extension  of  the  lesion  was  stressed  particularly  in  early
studies made on mice  (29),  rabbits (30),  and monkeys  (31).  Lauche  (32)
in 1927  considered that the reversed flow of lymph  resulting  from  blocked
lymphatics was responsible for the spread of pneumococci through the human
lung.  More  recent investigations  in  man,  however,  as  well  as  in  dogs
and  rats, indicate  that  pneumococcal  pneumonia  extends  principally  by
way of  the  edema-filled  alveoli  at  the  margin  of  the  lesion.  Loeschcke
(28)  made a detailed examination of serial  sagittal  sections  of  the lungs of
50 patients  dead  of  pneumonia  and  concluded  that  the  organisms  were
carried into adjacent  alveoli through the pores of Cohn by  infected  edema
fluid.  He suggested  that  the  process  was  aided  by  the  changes  in  the
intra-alveolar pressure associated with breathing and coughing.  Robertson
and  his  coworkers  (33)  and  Gunn  and  Nungester  (20)  expressed  similar
views  after  studying the  pathogenesis  of experimental  pneumonia  in dogs
and  rats,  respectively.
The results of the present  study support the views of Loeschcke.  Pneu-
mococci were  seldom  found  in lymphatics  in any of  the sections  studied.
On the other hand, the edema zone at its margin was a striking feature of
the  spreading  lesion.  Pneumococci,  which  were  most  numerous  in  this
outer  area,  could  be  seen  in great  numbers  floating  freely  in the  edema
fluid.  The  fact  that  inert  mucin  particles  were  washed  outward  to  the
margin of the lesion by the advancing edema fluid suggested  strongly that
organisms were  likewise transported  to  new alveoli by the liquid  medium.
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In addition, evidence has been mentioned that infected fluid probably causes
the extension of pneumonia  to other lobes and may even be responsible for
invasion of the pleural cavity.  In connection with the role of edema fluid in
causing  the  spread  of pneumococcal  pneumonia,  it is of great  theoretical
interest that Sutliff and Friedemann  (34)  have isolated from growing pneu-
mococci an "edema-producing  substance"  which  is  thought  to  be  respon-
sible for the local outpouring  of fluid at the site of pneumococcic  infections.
The  substance  has been  separated  from the capsular polysaccharide  of the
pneumococcus,  is species  specific rather than type specific,  and seems to be
non-antigenic.
No adequate explanation  can at present  be given for the phagocytic  re-
action  consistently  observed  in  the  lungs  of  rats  dying  of  pneumonia.
Phagocytosis  of  pneumococci  by  alveolar  leucocytes  was  observed  in  all
lesions more than  12 hours old, even though many of the animals had bac-
teriemia  when  sacrificed.  In  both  man  (35)  and  experimental  animals
(36)  circulating opsonins are rarely found in the presence  of positive  blood
cultures, and although serological  tests were not done in these experiments,
it is only reasonable  to suppose  that specific  antibodies  were absent  from
the blood in many instances.  In spite of this, not only was unmistakable
phagocytosis  observed  in  the lungs,  but  the  fact  that pneumococci  were
absent from the older,  central portion of the lesion indicated that organisms
were  being  efficiently  destroyed  by the  phagocytic  cells.  As  repeatedly
emphasized,  fully encapsulated living pneumococci cannot be phagocytized
unless they are first opsonized; therefore, the presence of active phagocytosis
in the lungs  of these  animals  is not easily  explained.  Robertson  (33)  has
observed  phagocytosis  in  the  pneumonic  lungs  of  dogs  under  the  same
circumstances.  He has  suggested  that  immune  bodies  may  be produced
locally in the lungs and thus cause phagocytosis and clearing  of  the  lesion
without overflowing into the blood stream in detectable amounts.  No data
are as yet available  supporting  Robertson's hypothesis,  but an attempt is
being  made  to  investigate  further  this  important  phenomenon,  since  it
obviously has a direct bearing  upon the mechanism  of recovery.  Regard-
less  of  the  explanation  of  the phagocytic  reaction,  its  presence,  and  par-
ticularly  its  efficiency,  indicate  that  the  lung  possesses  a  strong  natural
defence  against pneumococcal  infections.  In an actively spreading lesion,
however, leucocytes have not had time to reach the alveoli in the advancing
edema zone, and here in the absence of phagocytes,  pneumococci  can mul-
tiply freely  and invade the surrounding normal lung.
Although the effectiveness  of antipneumococcal  serum in the treatment of
lobar pneumonia is well  established,  the action of antibody  upon the pul-W.  BARRY  WOOD,  JR.
monary  lesion  has  not  been  understood.  Considerable  experimental
evidence has accumulated  indicating that antibody  cannot penetrate  areas
of consolidation  within the lung.  It has been shown that the circulation in
the pneumonic lung is impaired, and this fact has been advanced as evidence
that antibody cannot enter the lesion  (7,  37, 38).  Fox  (8) investigated  the
permeability of the lungs of rabbits to antibodies and reported that the lung-
blood  barrier  was  only  slightly permeable  even  in the presence  of  an  in-
flammatory  process.  More  recently,  Kempf  and  Nungester  (38)  have
studied the penetration of antipneumococcal  immune bodies into pneumonic
lesions produced in rats and have been unable to demonstrate  the presence
of either horse or rabbit antibody in the lungs following intravenous  treat-
ment.  Nye and Harris (9) measured the amount of capsular polysaccharide
in human lungs examined at autopsy,  and  calculated  that in certain cases
as much  as 60 liters of potent antiserum would  be required  to precipitate
the pneumococcal  carbohydrate contained in the consolidated lobes.  They
concluded that, even if antibody were able to enter the lesion, it could not
neutralize  all  of  the  antiphagocytic  polysaccharide  and,  therefore,  could
not be expected  to opsonize the offending  pneumococci.
In  the  present  paper,  however,  experiments  are  reported  which  dem-
onstrate  that  antipneumococcal  immune  bodies  not only  enter  the  pul-
monary lesion of experimental  pneumonia,  but do so  in amounts  sufficient
to control its spread.  None of the 76 animals treated with antiserum within
18 hours after inoculation died of pneumonia.  Study of the lungs at vari-
ous intervals after treatment revealed  that the type specific  antibody had
caused  agglutination  and  thus  fixation  of the  pneumococci  in the  edema
zone and even in large bronchi.  Pneumococci in the "zone of early consoli-
dation," though fewer in number, were also agglutinated.  The type specific
antibody at times appeared to cause the agglutinated organisms to stick to
the surrounding tissue as well as to each other.  This phenomenon has been
emphasized  by Rich  (39)  as an important factor in bringing about localiza-
tion  of  pneumococcal  infections  in  immunized  animals.  Besides  being
clumped,  many  of the organisms showed  swollen  capsules.  The  Quellung
reaction  is highly type specific and its presence  in the microscopic sections
proves  conclusively  that  the  changes  observed  were  due  to  type  specific
antibody.
Although phagocytosis  of pneumococci  occurs  in the lungs  of untreated
animals the process is relatively  slow, and only a few organisms are ingested
by any one leucocyte.  In serum-treated rats, on the other hand, the phago-
cytic reaction  appeared  to be greatly accelerated  by the opsonic action of
antibody.  Many  of  the  leucocytes  became  engorged  with  pneumococci
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and within 42 hours  after treatment practically  all of  the organisms in the
lesion had  been destroyed  by phagocytic cells.  It  is of interest that most
of the pneumococci were phagocytized  and digested by polymorphonuclear
leucocytes  and  that  the  process  was  completed  before  any  appreciable
number of macrophages had appeared  in the alveolar exudate.  Robertson
(33) has emphasized  the importance of the macrophage  reaction in bringing
about the final destruction of pneumococci in the lungs of untreated human
patients  and  also  of  untreated  dogs  with experimental  pneumonia.  The
fact that the polymorphonuclear leucocytes appear to play a more important
role  in the present  experiments may  well be explained  by the accelerated
phagocytic  reaction  caused  by  the  specific  psonins.  Evidence  will  be
presented  in  a  subsequent  report  that  macrophages  take  a  more  active
part in the destruction of pneumococci when  infected rats are  treated  with
sulfapyridine.
The  blood of  animals naturally  resistant  to pneumococcal  infections  is
capable  of  destroying  large  numbers  of  pneumococci  (40).  Bacteriemia
results  only when  the number  of  organisms  entering  the circulation  from
the pulmonary  lesion exceeds  that which  can be handled by the pneumo-
coccidal  properties  of  the blood.  Bacteriemia  may  be  controlled  by  de-
pressing the source of pneumococci in the lung, or by increasing the killing
power of  the blood.  Both mechanisms  are involved in the action of  anti-
serum.  The intravenous injection  of  specific antibody has been  shown  to
cause  immediate  agglutination  of  circulating  pneumococci;  the  clumped
organisms  become lodged in the capillaries  of  the  liver,  spleen,  lungs,  and
possibly  other  organs where  they  are  destroyed  by phagocytic  cells  (41).
In the  course of  the present study antibody has  also been found  to cause
agglutination and immobilization of pneumococci  within  the alveoli  of the
pneumonic  lesion.  Thus  it  becomes  evident  that  antiserum  exerts  its
dramatic effect upon bacteriemia not only by hastening the destruction  of
organisms already in the blood stream, but also by preventing pneumococci
still multiplying  in the lung from invading the circulation.  The resultant
effect  is rapid  sterilization  of  the  blood.
No  definite explanation  can as yet be offered  for the effect  of antiserum
upon early pleurisy.  Since organisms could not be found in any of the areas
of localized  pleurisy  observed in these  experiments,  no  conclusions  can be
drawn  regarding  the  action  of  antibody  upon the  pleural infection.  The
mere fact, however,  that serum treatment should lead to the localization  of
an infection already  involving the pleural cavity would seem of itself to be
of  considerable  importance.W.  BARRY  WOOD,  JR.
The results of the present experiments leave no doubt as to the ability of
type  specific  antibody to  penetrate  the pulmonary  lesion of experimental
pneumonia.  The presence  of agglutinated pneumococci  in the alveoli,  the
swelling of their capsules,  and the marked  increase in the phagocytosis  of
organisms  by the  cells  of the alveolar  exudate all serve as ample evidence
that  antibody  actually  entered  the  alveoli.  A  study  of  the  histological
changes  occurring  during  recovery  also  indicates  that  antipneumococcal
serum  exerts its curative  action in experimental  pneumonia  by halting the
pneumococci in the advancing edema zone through agglutination thus caus-
ing them to be overtaken and phagocytized by leucocytes.  Experiments to
be reported  in a subsequent paper have  shown that sulfapyridine  likewise
stops  the spread of the organisms at the margin of the lesion but  does so
through  a  different  mechanism.
It  has  been stated  that serum therapy  is  relatively  ineffective  in lobar
pneumonia  if instituted after the 4th day of the disease.  The explanations
offered for this commonly accepted  dictum are that antibody cannot pene-
trate  the  densely consolidated  lesion  of advanced  pneumonia  (42)  and  it
cannot  neutralize  all of  the antiphagocytic  polysaccharide  which  has  ac-
cumulated  in the pneumonic  exudate  (9).  Neither of  these  explanations
appears to be valid in the light of the present results.  It  has been shown
that type specific  antibody acts principally upon the advancing margin of
the lesion  in experimental  pneumonia.  Since  there is good  evidence  that
most of the pneumococci  in both human and experimental  pneumonia  are
at the border of the lesion,  there is no reason to believe  that intravenously
administered  antiserum must penetrate  areas  of advanced  consolidation  in
order to control the infection.  On the contrary, it has been repeatedly ob-
served in both man and laboratory animals  (33) that the cells of the alveolar
exudate in densely consolidated  areas are themselves capable of destroying
pneumococci  without the aid of serotherapy.  Were this not the case, lung
abscesses would be frequent rather than extremely rare sequelae of untreated
pneumonia.  Neither  is  there  any  reason  to  believe  that  intravenously
injected antibody must neutralize all of the polysaccharide  in the pneumonic
lesion.  Much  of the  polysaccharide  is contained  within  the consolidated
portion of the lesion where it cannot possibly offset the action of antibody
at the margin.  The apparent ineffectiveness  of late serum therapy, there-
fore,  cannot be explained either by the advanced  stage  of consolidation  or
by the  amount of polysaccharide  in  the lung.  Admitting  that the  exact
cause  of death,  as in any severe infection, is often obscure, it would  seem
probable that many failures have been due in the past to inadequate  doses
of antiserum (43) rather than to the inability of antibody to affect the lesion.
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SUMMARY
A uniformly fatal lobar pneumonia was produced in white rats by inocula-
tion of the left main bronchus with virulent Type I pneumococci suspended
in mucin.  All of the animals succumbed  in  less than 5 days,  half of them
dying within 48 hours.  In only 5 of 40 rats was the lesion confined  to the
left lung, and all but one developed pleurisy, pericarditis, or both.  All had
bacteriemia  at the time of death.
The pathogenesis  of the pulmonary lesion was studied by examining the
lungs  of  35  rats  killed  at  various  intervals  following  inoculation.  The
pneumonic process spread rapidly until most of the left lung was involved in
36 hours.  Frequent blood cultures showed invasion of the blood stream in
a few  rats at 6 hours and  in over  90 per cent  at the  end of the first  day.
The first signs of pleurisy usually appeared at 18 hours.
Microscopic  examination of  the actively spreading  lesion  revealed  three
characteristic  zones:  (1)  an outer  "edema zone"  in which  the alveoli  con-
tained many pneumococci floating freely in edema fluid,  (2)  a middle zone
where both leucocytes and organisms were present, many of the latter being
phagocytized,  and (3) an inner zone of advanced consolidation in which the
alveoli  contained many leucocytes but no  organisms  and where  there were
already  local  areas  of early resolution.  Study of numerous  lesions,  at in-
tervals of from  12 to 36 hours after inoculation, indicated that the pneumo-
cocci  spread into normal  alveoli principally  by way  of the infected  edema
fluid  in the outer zone.  Pneumococcus-laden  edema fluid  in large bronchi
and  in alveoli  beneath the pleura suggested  the mode  of spread  of  the in-
fection  to other  lobes  and  possibly  to  the  pleural  cavity.  No adequate
explanation  could  be found  for  the presence  of  active  phagocytosis  in the
lungs of animals with bacteriemia and presumably without circulating anti-
bodies,  but this conspicuous  phagocytic reaction  was obviously responsible
for  the clearing  of  the central part of  the spreading  lesion.
The action  of  type specific  antibody  upon  the  pulmonary lesion  of  ex-
perimental  lobar  pneumonia  was  studied  in  rats  similarly  infected  but
treated with antipneumococcal  serum.  When injected intravenously  in  a
single  dose  within  18  hours  after inoculation  the  antiserum  was  found to
protect all of  the rats against  the otherwise  fatal  pneumonia.  It stopped
the spread  of the pneumonic lesion,  cleared  the blood stream of  organisms,
and  prevented  the  extension  of  early  pleurisy.  The antibody  caused  ag-
glutination  and capsular  swelling  of the pneumococci in the lung, particu-
larly  in the edema zone at the margin of the lesion where they were  most
numerous.  Apparently  immobilized  by  agglutination  the organisms  wereW.  BARRY  WOOD,  JR.
overtaken  by leucocytes and destroyed  by phagocytosis.  The phagocytic
reaction  was greatly accelerated  by the specific opsonins of the antiserum,
and  the  pneumococci  were  destroyed  by  polymorphonuclear  leucocytes
before  many  macrophages  appeared  in  the  alveolar  exudate.  Within  a
week  after treatment resolution  of the pulmonary lesion was  well in prog-
ress.  Both horse and rabbit antibody were shown  to  penetrate  the lung,
and  immune bodies  were  demonstrated  in the  alveoli  within  10  minutes
after the start of treatment.
The relation of the observed  phenomena  to the curative action of anti-
pneumococcal  serum has been briefly  discussed, and it is pointed out that
the principal effect of antiserum is to cause immobilization  of the pneumo-
cocci in the advancing edema zone.  Experiments to be reported in a later
publication have shown that sulfapyridine  exerts a similar effect through  a
different mechanism.
The  author  wishes  to thank  Dr. John  Enders  for much  helpful advice,  Mr. John
Burke  for preparation  of  the  microscopic  sections,  and  Dr.  G.  O.  Favorite  and  Mr.
Leo  Talbert  for the photomicrographs.
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EXPLANATION  OF  PLATES
Sections  stained  by the  Gram-Weigert  technique.  Figs.  1, 2,  4, 7-13,  16-20 photo-
graphed by Dr.  G.  O. Favorite; Figs. 3,  5,  6, 14,  15 photographed  by Mr. L. Talbert.
PLATE  9
FIG.  1.  Gross lesion in rat dying of pneumonia 90 hours after inoculation.  Unilobar
left  lung  is  completely  consolidated.  Interlobar  fissure  between  upper,  middle,  and
lower lobes can be seen in the right lung.  Small postcardiac  lobe is not visible in pos-
terior view.  X 2.
FIG.  2.  Edema  zone  at  margin  of  lesion.  No  leucocytes  in  edema-filled  alveoli.
Leucocytic  exudate  can  be  seen  in  alveoli  bordering  on  inner  margin  of edema  zone
(upper  right).  Lesion  is  spreading  downward  toward  left.  X  160.
(Figs.  2  to 9  are  all photomicrographs  of  24 hour lesions.)
FIG.  3.  Pneumococci  in  edema-filled  alveoli  at margin  of  lesion.  Leucocytes  have
not yet entered  these alveoli.  Organisms  apparently  float  about in edema fluid  while
multiplying freely.  X  800.
FIG.  4.  Pneumococcus-laden  edema  fluid  in  alveoli  bordering  on visceral  pleura.
Suggests possibility  of direct invasion  of pleural cavity.  X 800.
FIG.  5.  Pneumococci  in edema fluid contained within  the lumen of a large bronchus.
Infected bronchial fluid probably causes spread of pneumonia to other lobes.  X  1250.THE  JOURNAL  OF  EXPERIMENTAL  MEDICINE  VOL.  73
(Wood:  Mechanism  of  recovery  in  pneumococcal  pneumonia.  I)
PLATE  9PLATE  10
FIG.  6.  Both  pneumococci  and leucocytes  in  alveoli  within  zone  of  early consolida-
tion.  This  area  borders  on  outer  edema  zone  (see  Fig.  2).  Organisms  are plentiful,
but a few are already  being phagocytized  by leucocytes,  although  rat  had bacteriemia
when  sacrificed.  X  800.
FIG.  7.  Leucocytic exudate  in  inner  zone  of  advanced  consolidation.  Pneumococci
have  been  phagocytized  and  are no  longer  visible.  Cells of  exudate are  still predomi-
nantly polymorphonuclear.  X  800.
FIG.  8.  Early  macrophage  reaction  and  clearing  of  exudate  in  central  area  of  ad-
vanced  consolidation.  Rat  had  heavy  bacteriemia  when  sacrificed.  X  800.
FIG.  9.  Fibrin  deposits  in  alveoli  in  zone  of  consolidation  near  center  of  lesion.
X 800.THE JOURNAL  OF  EXPERIMENTAL  MEDICINE  VOL.  73
(Wood: Mechanism  of  recovery  in  pneumococcal  pneumonia.  I)
PLATE  10PLATE  11
FIG.  10.  Clumps of agglutinated pneumococci  (see arrows)  in  edema zone at margin
of  lesion.  Note  small  vacuoles  in  edema  fluid.  The  rat  was  sacrificed  6  hours after
treatment.  X  160.
(All figures  except  16,  17,  and  20  are  photomicrographs  of  lungs  taken  from  rats
treated  18 hours after  inoculation.  Fig.  16,  17,  and 20  show lesions  in  animals treated
at  12  hours.)
FIG.  11.  Agglutination  of  pneumococci  within  the  alveoli  6  hours  after  treatment.
No leucocytes  have  as yet reached these alveoli in the outer edema zone.  Many of the
organisms  appear to cling  to the alveolar  walls as  well  as  to  each other.  X  800.
FIG.  12.  Agglutinated pneumococci  within the lumen  of a large bronchus.  Although
many leucocytes are  present in  the bronchial exudate  few contain  organisms.  X  800.THE  JOURNAL  OF  EXPERIMENTAL  MEDICINE  VOL.  73
(Wood:  Mechanism  of recovery  in pneumococcal  pneumonia.  I)
PLATE  1PLATE  12
FIG.  13.  Large clumps of agglutinated  pneumococci  in an area of  early consolidation
6 hours after  treatment.  The large  size  of  the clumps  may  be due  in  part to the  con-
tinued multiplication of  the agglutinated  organisms.  It  seems  unlikely that leucocytes
can  attack  such  large  masses  of  bacteria  directly,  and  it is  conceivable  that  autolysis
plays  an  important  r6le  in  their  final  destruction.  Agglutination  of  pneumococci  in
such areas indicates  that antibody  can penetrate  the zone  of early consolidation  as well
as  the edema zone  at the margin  of  the lesion.  X  800.
FIG.  14.  Agglutinated  pneumococci  with  swollen  capsules  characteristic  of  Neufeld
Quellung reaction.  Rat  sacrificed  6  hours  after treatment.  X  1500.
FIG.  15.  Higher  magnification  of  Quellung reaction.  X  3750.
FIG.  16.  Phagocytosis  of  pneumococci  by  polymorphonuclear  leucocytes  in  alveolar
exudate  6  hours  after  treatment.  X  800.
FIG.  17.  Higher  magnification  of  leucocytes  containing  pneumococci  with  swollen
capsules.  X  1800.THE  JOURNAL  OF  EXPERIMENTAL  MEDICINE  VOL.  73
(Wood:  Mechanism  of  recovery  in  pneumococcal  pneumonia.  I)
PLATE  12PLATE  13
FIG.  18.  Margin  of lesion  18 hours  after treatment  showing  complete  disappearance
of edema zone.  X  160.
FIG.  19.  Alveolar  exudate  near  margin  of  lesion  42  hours  after  treatment.  The
pneumococci have been  destroyed by the phagocytic  cells.  Although macrophages  are
present  the  exudate  still contains  many  polymorphonuclear  leucocytes.  X 800.
FIG.  20.  Advanced  macrophage  reaction with  marked clearing  of  the  lesion  1 week
after  treatment.  The  alveolar  walls  are  noticeably  thickened  and  a  few  large  pale
macrophages  can  be seen  free  in  the  alveoli.  X 800.THE JOURNAL  OF  EXPERIMENTAL  MEDICINE  VOL.  73
(Wood:  Mechanism  of recovery  in  pneumococcal  pneumonia.  I)
PLATE  13